Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeted pharmacogenetic analysis of antipsychotic response in the CATIE study.

Pharmacogenomics - 1 Aug 2012

Liu Qian, Jamba Maidar, Patrick Calvin, Padmanabhan Saranya, Brennan Mark D

Abstract excerpt

AIM: This study evaluated the impact of 6789 SNPs on treatment response to antipsychotics in Caucasian patients from the CATIE study. MATERIALS & METHODS: An Illumina (CA, USA) BeadChip was designed that targeted genes potentially impacting disease risk, disease presentation or antipsychotic response. SNPs tagged regions of linkage disequilibrium or functional variants not detectable using previous genotypes for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Biomarkers, Pharmacological
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Linkage Disequilibrium

Share to Pharmacogenetics

Share to Schizophrenia

Share to United States

Share to White People

Source

Open in PubMed Open full text

Identifiers

PMID: 22920393
DOI: 10.2217/pgs.12.105
PMCID: PMC3518380

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeted pharmacogenetic analysis of antipsychotic response in the CATIE study.PMID 22920393Read ↗

Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis.Semantic proximity Read ↗

Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.Semantic proximity Read ↗

Genomewide association for schizophrenia in the CATIE study: results of stage 1.Semantic proximity Read ↗

Genotypic variation in the SV2C gene impacts response to atypical antipsychotics the CATIE study.Semantic proximity Read ↗

Toward understanding genetic risk for differential antipsychotic response in individuals with schizophreniaSemantic proximity Read ↗

Genome-wide association study on antipsychotic-induced weight gain in the CATIE sample.Semantic proximity Read ↗

The identification of novel genetic variants associated with antipsychotic treatment response outcomes in first-episode schizophrenia patients.Semantic proximity Read ↗

Recent Progress in Pharmacogenomics of Antipsychotic Drug Response.Semantic proximity Read ↗

Evidence for a SULT4A1 haplotype correlating with baseline psychopathology and atypical antipsychotic response.Semantic proximity Read ↗

Pharmacogenomics can improve antipsychotic treatment in schizophreniaSemantic proximity Read ↗

Delineating significant genome-wide associations of variants with antipsychotic and antidepressant treatment response: implications for clinical pharmacogenomics.Semantic proximity Read ↗

A candidate gene study of tardive dyskinesia in the CATIE schizophrenia trialSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.